Aly Yasser
Medical Science Liaison
Dubai
Summary
Qualified field based medical personnel who contributes to the medical guidance for a Brand. Will typically work with more senior colleagues to ensure that all local Medical requirements are met for brand material. Will use medical knowledge to contribute to the marketing direction of the brand. May also contribute to other project where medical knowledge would add value
Overview
6
6
years of professional experience
8
8
years of post-secondary education
2
2
Certifications
3
3
Languages
Work History
Medical Science Liaison
Novartis Oncology
Dubai, Gulf Region
02.2022 - Current
- Build, enhance and maintain the engagement with scientific leaders
- Build and maintain trust based relationships with external stakeholders
- Develop or initiate scientific programs to explore unmet medical needs in priority disease areas (Breast Cancer - Lung Cancer)
- Act as scientific expert in priority disease areas for internal stakeholders
- Continuously demonstrate development of scientific expertise in disease areas of company focus
- Compliance with relevant company and industry code of Conduct and also to comply with local country codes
Product Specialist
Novartis Oncology
Dubai, UAE
01.2020 - 01.2021
- Responsible for Oncology Total portfolio including Breast Cancer Disease Area (Piqray, Kisqali),
- NET and Acromegaly Disease Area (Sandostatin LAR)
- Successfully Launched the First PI3K Inhibitor (PIQRAY) in UAE market and support other MEA countries in their launch preparation
- Formulary Inclusion of PIQRAY in SEHA
- Ensure Kisqali position as the first Choice in 1st line setting HR+HER2- aBC in UAE
- Protect SAS-LAR leadership in NET and Acromegaly Market in UAE, Novartis | oncology | Qatar-Bahrain
Product Specialist
Novartis Oncology
Doha, Qatar
01.2018 - 12.2019
- Responsible for Oncology Total portfolio including Breast Cancer Disease Area (Kisqali,Affinitor, Femara), NET and Acromegaly Disease Area (Sandostatin LAR), RCC and STS Disease Area (Votrient, Tykerb)
- Succeeded to position KISQALI in NCCCR breast cancer management protocol
- Formulary inclusion of KISQALI in less than 11 months to be on the pharmacy shelf
- Formulary inclusion of SAS-LAR 30 mg as a dose extension in only 3 months
- Succeeded to enlist of SAS-LAR in the exemption list of the NCCCR
Product Specialist
Novartis Oncology
Doha, Qatar - Bahrain
01.2017 - 01.2018
- Responsible for raising Disease Awareness about Rare tumors (Acromegaly – NET) in order to help the physicians to early diagnose patients.
- Succeeded to ensure SAS-LAR availability in Bahrain private sector for the first time.
- Commitment and exceeding achievement of sales figures in Consumption and patient recruitment.
- Achieve high level of engagement with key thought leaders, decision maker, pharmacists, Nurses and Purchasers in Both Countries
Medical Representative
Sanofi | Specialty care
Doha, Qatar
09.2015 - 12.2016
- Achieve high level of engagement with key thought leaders & decision maker in both institution & Trade sector
- Best Achiever GULF Region
- Succeed in proper positing and implementing of Clexane in HMC VTE prophylaxis protocol
- Formulary inclusion of Tritace in Qatar Red Crescent (QRC)
- Achieving 38% growth Vs PY in Clexane.
Medical Representative
AstraZeneca | CVM
Alexandria, Egypt
09.2014 - 09.2015
- Ranked 1 Nationally YTD September
- Member of Crestor Brand Team
Education
MBA - Strategic Marketing
Cardiff Metropolitan University
UK 06.2019 - Current
B.Sc. - Pharmacy
Alexandria University
01.2009 - 01.2014
Certification
Harvard Medical School - Certificate of Achievement - Cancer Genomic and precision Oncology
Affiliations
Curious Award - Novartis Oncology - Gulf Region 2021
Performance Award - Novartis Oncology - Gulf Region 2018
Additional Courses
- Managerial Training
- Novartis competitive Selling Model training
- Leadership and Organizational behavior training
- Finance training
- Emotional intelligence training
- Negotiation skills training
- Customer Centricity interaction training
Timeline
Medical Science Liaison
Novartis Oncology
02.2022 - Current
Harvard Medical School - Certificate of Achievement - Cancer Genomic and precision Oncology
10-2021
Chartered Management Institute - Certified Manager Programme
01-2020
Product Specialist
Novartis Oncology
01.2020 - 01.2021
MBA - Strategic Marketing
Cardiff Metropolitan University
06.2019 - Current
Product Specialist
Novartis Oncology
01.2018 - 12.2019
Product Specialist
Novartis Oncology
01.2017 - 01.2018
Medical Representative
Sanofi | Specialty care
09.2015 - 12.2016
Medical Representative
AstraZeneca | CVM
09.2014 - 09.2015
B.Sc. - Pharmacy
Alexandria University
01.2009 - 01.2014